Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.27 trillion and total revenue of $117.14 billion.
Market Cap
1.27T
Revenue
117.14B
Profits
-35.32B
PE Ratio
n/a
Profit Margin
-30.15%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.06B | 0.68% | 1,019,888 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 83.03B | 4.59% | 17,638,152 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 81.49B | 1.04% | 726,152 | 15.53B |
| 4 | ARGX | argenx SE | 54.55B | 1.51% | 290,153 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 41.62B | -1.30% | 518,310 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 39.91B | 1.26% | 1,171,970 | - |
| 7 | RPRX | Royalty Pharma plc | 37.54B | 0.80% | 2,701,905 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.35B | -0.38% | 1,603,484 | 4.80B |
| 9 | GMAB | Genmab A/S | 26.70B | -0.04% | 4,929,101 | 4.13B |
| 10 | ROIV | Roivant Sciences Ltd. | 26.39B | 1.36% | 6,567,958 | 7.53M |
| 11 | INCY | Incyte Corporation | 23.63B | 2.90% | 2,230,895 | 5.82B |
| 12 | BNTX | BioNTech SE | 21.87B | 0.23% | 1,076,779 | 3.03B |
| 13 | INSM | Insmed Incorporated | 20.74B | 1.75% | 3,349,379 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 16.19B | 0.37% | 1,431,715 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 16.15B | 0.29% | 599,081 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.58B | 0.38% | 1,699,538 | 1.66B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.56B | 1.79% | 2,041,951 | 713.07M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 13.42B | 0.53% | 605,813 | 4.60B |
| 19 | SMMT | Summit Therapeutics Inc. | 12.26B | 5.72% | 4,739,591 | - |
| 20 | TECH | Bio-Techne Corporation | 11.39B | -0.12% | 2,429,361 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.71B | -0.72% | 2,463,412 | 3.41B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.17B | 0.59% | 209,579 | 1.28B |
| 23 | TWST | Twist Bioscience Corporation | 10.02B | 10.05% | 1,758,420 | 431.80M |
| 24 | KYMR | Kymera Therapeutics, Inc. | 9.78B | 2.38% | 828,870 | 105.00M |
| 25 | PCVX | Vaxcyte, Inc. | 9.55B | 1.17% | 2,587,481 | - |
| 26 | CAI | Caris Life Sciences, Inc. | 9.51B | 3.74% | 3,380,703 | 989.61M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.49B | 2.21% | 212,809 | 440.48M |
| 28 | CORT | Corcept Therapeutics Incorporated | 9.47B | 0.53% | 925,520 | 830.81M |
| 29 | SYRE | Spyre Therapeutics, Inc. | 9.26B | 6.60% | 944,931 | - |
| 30 | IBRX | ImmunityBio, Inc. | 9.15B | 10.50% | 10,508,798 | 165.79M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.13B | 0.57% | 865,926 | 281.99M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.55B | 1.30% | 1,148,269 | 67.67M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.34B | 0.08% | 2,118,861 | 669.50M |
| 34 | TGTX | TG Therapeutics, Inc. | 8.01B | 3.01% | 1,484,886 | 799.54M |
| 35 | ABVX | ABIVAX Société Anonyme | 7.76B | 0.58% | 740,272 | 5.33M |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 7.47B | 0.07% | 388,227 | 7.46M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 7.45B | -1.29% | 1,104,433 | 776.57M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.31B | 1.24% | 2,376,842 | 874.09M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.60B | 5.81% | 8,804,154 | 324.97M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.35B | 3.03% | 400,170 | 239.92M |
| 41 | ORKA | Oruka Therapeutics, Inc. | 6.34B | 6.07% | 1,205,562 | - |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 6.21B | 1.11% | 143,353 | 290.54M |
| 43 | IMVT | Immunovant, Inc. | 5.97B | 2.52% | 1,058,000 | - |
| 44 | MANE | Veradermics, Incorporated | 5.88B | 2.42% | 466,912 | - |
| 45 | BLTE | Belite Bio, Inc | 5.87B | 1.65% | 138,130 | - |
| 46 | KOD | Kodiak Sciences Inc. | 5.73B | 1.92% | 1,010,421 | - |
| 47 | CGON | CG Oncology, Inc. | 5.58B | 2.24% | 709,343 | 6.23M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.56B | 3.56% | 1,838,365 | - |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.56B | 2.75% | 563,279 | 618.07M |
| 50 | ERAS | Erasca, Inc. | 5.32B | 1.53% | 5,825,748 | - |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.18B | 1.67% | 1,117,062 | 1.01B |
| 52 | SRRK | Scholar Rock Holding Corporation | 5.17B | 1.87% | 1,161,010 | - |
| 53 | DFTX | Definium Therapeutics, Inc. | 4.98B | 3.92% | 1,282,374 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 4.98B | 5.02% | 1,166,901 | 13.39M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.80B | 1.82% | 3,450,125 | 591.33M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.45B | 0.24% | 748,689 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.29B | 0.92% | 942,050 | - |
| 58 | LEGN | Legend Biotech Corporation | 4.18B | 5.74% | 2,121,832 | 1.27B |
| 59 | ABCL | AbCellera Biologics Inc. | 4.16B | 6.21% | 3,460,357 | 66.17M |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.13B | 3.97% | 2,258,312 | 10.35M |
| 61 | ARQT | Arcutis Biotherapeutics, Inc. | 3.98B | -0.41% | 2,224,234 | 463.98M |
| 62 | TNGX | Tango Therapeutics, Inc. | 3.86B | 3.11% | 3,322,936 | 53.81M |
| 63 | IRON | Disc Medicine, Inc. | 3.55B | 2.88% | 1,469,726 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.49B | 0.67% | 1,089,965 | 7.50M |
| 65 | ACAD | Acadia Pharmaceuticals Inc. | 3.48B | 2.18% | 1,332,125 | 1.14B |
| 66 | CELC | Celcuity Inc. | 3.33B | 3.45% | 885,827 | - |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.27B | 5.91% | 1,572,918 | 148.00K |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 3.23B | 1.89% | 1,000,834 | 234.13M |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.20B | 5.30% | 3,308,456 | - |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.16B | 7.76% | 3,002,014 | - |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.12B | 0.44% | 224,849 | 890.79M |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 3.11B | 1.04% | 747,960 | 606.33M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.07B | 3.00% | 1,482,167 | 3.60M |
| 74 | NRIX | Nurix Therapeutics, Inc. | 2.92B | 4.50% | 2,563,026 | 701.94M |
| 75 | VKTX | Viking Therapeutics, Inc. | 2.90B | 2.81% | 3,329,806 | - |
| 76 | VRDN | Viridian Therapeutics, Inc. | 2.73B | 3.21% | 2,808,729 | 71.13M |
| 77 | ZLAB | Zai Lab Limited | 2.65B | -3.12% | 1,539,675 | 449.61M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.61B | 2.14% | 2,231,836 | 117.00M |
| 79 | MBX | MBX Biosciences, Inc. | 2.55B | 5.33% | 492,993 | - |
| 80 | ADMA | ADMA Biologics, Inc. | 2.50B | 0.95% | 2,219,177 | 512.28M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.49B | 4.67% | 2,750,678 | 156.04M |
| 82 | SLS | SELLAS Life Sciences Group, Inc. | 2.46B | 7.32% | 6,218,800 | - |
| 83 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | 4.97% | 1,967,770 | 7.12M |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.42B | 6.58% | 22,169,969 | 54.86M |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.37B | 2.20% | 746,583 | 158.00K |
| 86 | FTRE | Fortrea Holdings Inc. | 2.32B | 2.52% | 1,973,479 | 2.68B |
| 87 | BHVN | Biohaven Ltd. | 2.31B | 5.81% | 2,430,645 | - |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.30B | 1.23% | 494,480 | 311.51M |
| 89 | AGIO | Agios Pharmaceuticals, Inc. | 2.27B | 3.20% | 739,087 | 98.34M |
| 90 | PHVS | Pharvaris N.V. | 2.24B | 1.30% | 230,116 | - |
| 91 | XNCR | Xencor, Inc. | 2.23B | 2.78% | 2,109,166 | 104.97M |
| 92 | VCEL | Vericel Corporation | 2.22B | 0.53% | 558,367 | 306.30M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | 3.04% | 736,932 | 959.90M |
| 94 | PGEN | Precigen, Inc. | 2.20B | 1.82% | 3,790,137 | 85.72M |
| 95 | VERA | Vera Therapeutics, Inc. | 2.16B | 5.97% | 1,069,767 | - |
| 96 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.14B | 8.97% | 3,110,351 | 208.78M |
| 97 | IMNM | Immunome, Inc. | 2.13B | 4.92% | 1,226,156 | 4.02M |
| 98 | SEPN | Septerna, Inc. | 2.06B | 6.67% | 261,832 | 98.88M |
| 99 | ZYME | Zymeworks Inc. | 2.05B | 1.69% | 1,125,677 | 37.13M |
| 100 | ADRX | ADARx Pharmaceuticals, Inc. | 2.03B | 1.80% | 293,664 | 6.13M |
| 101 | LKFT | Lakefront Biotherapeutics NV | 2.01B | 0.41% | 170,822 | 1.13B |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | 5.06% | 2,226,641 | 1.97B |
| 103 | VIR | Vir Biotechnology, Inc. | 1.96B | 4.80% | 1,973,612 | 303.23M |
| 104 | PVLA | Palvella Therapeutics, Inc. | 1.92B | 5.29% | 178,774 | - |
| 105 | TRAX | First Tracks Biotherapeutics, Inc. | 1.91B | 4.37% | 618,043 | - |
| 106 | TRVI | Trevi Therapeutics, Inc. | 1.90B | 6.71% | 2,100,265 | - |
| 107 | MLYS | Mineralys Therapeutics, Inc. | 1.87B | 2.77% | 3,199,926 | - |
| 108 | ABSI | Absci Corporation | 1.81B | 11.85% | 5,837,389 | 1.56M |
| 109 | COAG | Hemab Therapeutics Holdings, Inc. | 1.79B | 6.61% | 380,060 | - |
| 110 | BRVE | Braveheart Bio, Inc. | 1.78B | -0.23% | 156,109 | - |
| 111 | ZBIO | Zenas BioPharma, Inc. | 1.78B | 0.22% | 581,012 | 1.00M |
| 112 | MAZE | Maze Therapeutics, Inc. | 1.76B | 2.00% | 624,987 | 20.00M |
| 113 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 9.06% | 3,851,011 | 59.51M |
| 114 | MESO | Mesoblast Limited | 1.72B | 6.38% | 215,600 | 120.25M |
| 115 | NBTX | Nanobiotix S.A. | 1.72B | 9.51% | 130,136 | 13.15M |
| 116 | KLRA | Kailera Therapeutics, Inc. | 1.70B | 2.82% | 841,719 | - |
| 117 | GENB | Generate Biomedicines, Inc. | 1.70B | 6.96% | 757,436 | 26.48M |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.69B | 2.63% | 1,325,216 | 27.59M |
| 119 | QURE | uniQure N.V. | 1.68B | 12.15% | 1,572,688 | 18.67M |
| 120 | URGN | UroGen Pharma Ltd. | 1.66B | -0.38% | 1,033,087 | 188.73M |
| 121 | NVAX | Novavax, Inc. | 1.65B | 6.60% | 6,774,688 | 413.80M |
| 122 | RARE | Ultragenyx Pharmaceutical Inc. | 1.65B | 4.17% | 4,944,538 | 717.00M |
| 123 | IMCR | Immunocore Holdings plc | 1.65B | 2.17% | 314,115 | 430.78M |
| 124 | NUVB | Nuvation Bio Inc. | 1.60B | 0.89% | 5,055,358 | 169.90M |
| 125 | GPCR | Structure Therapeutics Inc. | 1.54B | 2.13% | 731,614 | - |
| 126 | INVA | Innoviva, Inc. | 1.51B | -0.52% | 584,440 | 440.00M |
| 127 | LYCA | Lycia Therapeutics, Inc. | 1.51B | -9.50% | 426,849 | 4.44M |
| 128 | ANAB | AnaptysBio, Inc. | 1.48B | 1.76% | 349,580 | 106.09M |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.48B | 5.39% | 523,034 | - |
| 130 | OCUL | Ocular Therapeutix, Inc. | 1.48B | 3.86% | 2,215,307 | 52.06M |
| 131 | INBX | Inhibrx Biosciences, Inc. | 1.41B | 7.96% | 374,216 | 1.30M |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.38B | 5.99% | 2,824,718 | 5.49M |
| 133 | GHRS | GH Research PLC | 1.37B | 4.38% | 299,980 | - |
| 134 | KRSA | Korsana Biosciences, Inc. | 1.37B | -6.29% | 196,734 | - |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.36B | 3.29% | 286,094 | - |
| 136 | RAPP | Rapport Therapeutics, Inc. | 1.32B | 8.72% | 703,927 | 20.00M |
| 137 | AAPG | Ascentage Pharma Group International | 1.31B | -3.88% | 9,967 | 94.61M |
| 138 | NKTR | Nektar Therapeutics | 1.30B | 1.39% | 568,313 | 54.59M |
| 139 | LBRX | LB Pharmaceuticals Inc | 1.28B | 0.76% | 236,346 | - |
| 140 | KARD | Kardigan, Inc. | 1.27B | 7.68% | 452,753 | - |
| 141 | OMER | Omeros Corporation | 1.27B | 7.37% | 895,059 | 38.42M |
| 142 | DRTS | Alpha Tau Medical Ltd. | 1.25B | 4.81% | 342,107 | - |
| 143 | SVRA | Savara Inc. | 1.24B | 7.52% | 3,591,283 | - |
| 144 | REPL | Replimune Group, Inc. | 1.23B | 4.65% | 4,298,248 | - |
| 145 | VSTM | Verastem, Inc. | 1.23B | 1.00% | 4,708,400 | 87.53M |
| 146 | SNDX | Syndax Pharmaceuticals, Inc. | 1.22B | 3.56% | 2,704,660 | 252.25M |
| 147 | SLN | Silence Therapeutics plc | 1.19B | - | 1,488,216 | 615.00K |
| 148 | BCAX | Bicara Therapeutics Inc. | 1.16B | 3.49% | 609,332 | - |
| 149 | VOR | Vor Biopharma Inc. | 1.16B | 6.60% | 770,826 | - |
| 150 | AVLN | Avalyn Pharma Inc. | 1.15B | -4.83% | 961,286 | - |
| 151 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 2.16% | 219,356 | - |
| 152 | MNKD | MannKind Corporation | 1.06B | 1.86% | 2,509,730 | 393.63M |
| 153 | JANX | Janux Therapeutics, Inc. | 1.06B | 3.42% | 687,230 | 24.00M |
| 154 | CTY | City Therapeutics, Inc. | 1.04B | 0.34% | 214,811 | 14.34M |
| 155 | SGP | SpyGlass Pharma, Inc. | 1.03B | 3.31% | 69,340 | - |
| 156 | MLTX | MoonLake Immunotherapeutics | 1.02B | 1.02% | 934,417 | - |
| 157 | LTGO | Latigo Biotherapeutics, Inc. | 1.01B | -0.33% | 164,135 | - |
| 158 | IMTX | Immatics N.V. | 992.37M | 1.54% | 1,194,125 | 47.65M |
| 159 | CGEM | Cullinan Therapeutics, Inc. | 955.02M | 2.06% | 488,228 | - |
| 160 | RIGL | Rigel Pharmaceuticals, Inc. | 944.27M | 1.28% | 133,105 | 276.79M |
| 161 | JBIO | Jade Biosciences, Inc. | 937.43M | 1.66% | 652,902 | - |
| 162 | ODTX | Odyssey Therapeutics, Inc. | 934.41M | 1.04% | 241,163 | 99.00K |
| 163 | ORIC | ORIC Pharmaceuticals, Inc. | 932.87M | 0.45% | 4,938,899 | - |
| 164 | AKTS | Aktis Oncology, Inc. | 914.94M | 4.58% | 324,710 | 10.06M |
| 165 | ANRO | Alto Neuroscience, Inc. | 910.02M | 4.88% | 469,256 | - |
| 166 | GLUE | Monte Rosa Therapeutics, Inc. | 909.44M | 1.72% | 1,458,009 | 28.73M |
| 167 | MGTX | MeiraGTx Holdings plc | 902.80M | 2.40% | 722,943 | 397.50M |
| 168 | CRVS | Corvus Pharmaceuticals, Inc. | 886.63M | 0.86% | 1,133,596 | - |
| 169 | KURA | Kura Oncology, Inc. | 880.71M | 2.91% | 1,710,043 | 77.23M |
| 170 | OBX | Obsidian Therapeutics, Inc. | 880.26M | 2.81% | 397,721 | - |
| 171 | IVA | Inventiva S.A. | 862.19M | 0.68% | 1,782,685 | 2.81M |
| 172 | ALMS | Alumis Inc. | 859.45M | 2.00% | 3,261,305 | 7.40M |
| 173 | PHAR | Pharming Group N.V. | 851.70M | -0.25% | 19,190 | 386.75M |
| 174 | ABUS | Arbutus Biopharma Corporation | 848.77M | 2.14% | 1,622,726 | 181.72M |
| 175 | APMD | Apnimed, Inc. | 811.38M | 2.85% | 365,456 | 115.12M |
| 176 | PRME | Prime Medicine, Inc. | 773.88M | 20.50% | 8,824,721 | 4.07M |
| 177 | HELP | Helus Pharma Inc. | 768.59M | 1.54% | 1,527,250 | - |
| 178 | AVBP | ArriVent BioPharma, Inc. | 759.34M | 0.26% | 1,581,989 | - |
| 179 | DNA | Ginkgo Bioworks Holdings, Inc. | 758.92M | 12.48% | 3,008,245 | 132.42M |
| 180 | ARDX | Ardelyx, Inc. | 747.56M | - | 4,862,074 | 450.89M |
| 181 | SANA | Sana Biotechnology, Inc. | 739.42M | 4.66% | 2,620,837 | - |
| 182 | SGMT | Sagimet Biosciences Inc. | 738.87M | 9.00% | 1,108,768 | - |
| 183 | GERN | Geron Corporation | 738.84M | - | 6,709,314 | 204.56M |
| 184 | OABI | OmniAb, Inc. | 721.14M | 7.59% | 1,113,229 | 38.46M |
| 185 | ACHV | Achieve Life Sciences, Inc. | 713.11M | 5.96% | 1,486,048 | - |
| 186 | ANNX | Annexon, Inc. | 712.82M | 1.62% | 2,964,506 | - |
| 187 | SLBT | SL Science Holding Limited | 701.43M | - | 38,320 | 3.27M |
| 188 | GYRE | Gyre Therapeutics, Inc. | 692.40M | 7.58% | 126,373 | 109.82M |
| 189 | ANL | Adlai Nortye Group Ltd. | 689.70M | 1.23% | 71,157 | 18.06M |
| 190 | ATTO | Attovia Therapeutics, Inc. | 684.77M | 8.07% | 454,270 | 1.80M |
| 191 | WVE | Wave Life Sciences, Inc. | 679.82M | 7.48% | 4,195,850 | 70.92M |
| 192 | IMMX | Immix Biopharma, Inc. | 667.37M | -0.12% | 1,147,027 | - |
| 193 | DSGN | Design Therapeutics, Inc. | 665.24M | 2.80% | 388,875 | - |
| 194 | SLDB | Solid Biosciences Inc. | 663.72M | 6.54% | 1,551,485 | - |
| 195 | IAM | Iambic Therapeutics, Inc. | 663.61M | -2.85% | 439,755 | 18.25M |
| 196 | FDMT | 4D Molecular Therapeutics, Inc. | 660.72M | 8.43% | 1,134,654 | 92.01M |
| 197 | LXRX | Lexicon Pharmaceuticals, Inc. | 658.53M | 2.07% | 1,861,649 | 41.47M |
| 198 | AURA | Aura Biosciences, Inc. | 653.34M | 1.94% | 680,262 | - |
| 199 | CADL | Candel Therapeutics, Inc. | 631.28M | 5.91% | 928,461 | - |
| 200 | CRMD | CorMedix Inc. | 623.55M | 0.76% | 1,002,475 | 462.25M |
| 201 | OLMA | Olema Pharmaceuticals, Inc. | 615.98M | 6.34% | 2,190,117 | - |
| 202 | DBVT | DBV Technologies S.A. | 609.96M | 1.45% | 641,359 | 5.04M |
| 203 | NVCT | Nuvectis Pharma, Inc. | 600.80M | -0.27% | 144,635 | - |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 597.10M | 5.51% | 1,089,518 | 136.07M |
| 205 | STTK | Shattuck Labs, Inc. | 579.10M | 4.15% | 699,950 | 1.00M |
| 206 | MDXG | MiMedx Group, Inc. | 568.47M | 1.30% | 1,920,334 | 355.17M |
| 207 | CBIO | Crescent Biopharma, Inc. | 567.97M | 4.00% | 288,225 | 11.88M |
| 208 | PBYI | Puma Biotechnology, Inc. | 563.69M | 0.65% | 308,906 | 231.24M |
| 209 | ACRS | Aclaris Therapeutics, Inc. | 557.88M | - | 7,986,060 | 8.22M |
| 210 | CLYM | Climb Bio, Inc. | 549.66M | 8.63% | 3,904,391 | - |
| 211 | NGNE | Neurogene Inc. | 540.11M | 14.66% | 484,953 | 925.00K |
| 212 | ETRA | Electra Therapeutics, Inc. | 534.77M | 1.79% | 176,833 | - |
| 213 | DRUG | Bright Minds Biosciences Inc. | 532.90M | 5.73% | 59,413 | - |
| 214 | ENTX | Entera Bio Ltd. | 532.20M | 6.99% | 203,527 | 42.00K |
| 215 | VALN | Valneva SE | 523.40M | 2.96% | 16,134 | 163.30M |
| 216 | SRZN | Surrozen, Inc. | 516.63M | 8.25% | 431,579 | 11.51M |
| 217 | INDP | Indaptus Therapeutics, Inc. | 507.59M | -1.05% | 366,387 | - |
| 218 | CTMX | CytomX Therapeutics, Inc. | 503.35M | 3.82% | 3,734,082 | 18.30M |
| 219 | BLSM | BlossomHill Therapeutics, Inc. | 500.77M | -3.87% | 74,307 | - |
| 220 | FTH | Faeth Therapeutics, Inc. | 493.81M | 13.55% | 612,173 | - |
| 221 | ARVN | Arvinas, Inc. | 487.13M | 1.92% | 800,825 | 316.70M |
| 222 | OCS | Oculis Holding AG | 483.36M | -1.63% | 189,294 | 1.45M |
| 223 | MNPR | Monopar Therapeutics Inc. | 482.20M | 1.84% | 135,925 | - |
| 224 | PHAT | Phathom Pharmaceuticals, Inc. | 475.79M | 0.84% | 2,104,010 | 239.66M |
| 225 | DMAC | DiaMedica Therapeutics Inc. | 468.61M | -0.57% | 268,715 | - |
| 226 | EPRX | Eupraxia Pharmaceuticals Inc. | 468.30M | 3.36% | 486,206 | - |
| 227 | PROK | ProKidney Corp. | 458.02M | 11.40% | 1,367,605 | 818.00K |
| 228 | MPLT | MapLight Therapeutics, Inc. | 454.05M | 6.66% | 384,839 | - |
| 229 | PRTA | Prothena Corporation plc | 452.28M | 4.88% | 654,353 | 54.53M |
| 230 | OVID | Ovid Therapeutics Inc. | 441.37M | 4.87% | 1,691,781 | 1.58M |
| 231 | RGNX | REGENXBIO Inc. | 435.69M | 0.30% | 1,224,897 | 174.48M |
| 232 | RZLT | Rezolute, Inc. | 431.13M | 7.59% | 1,400,114 | - |
| 233 | YDES | YD Bio Limited | 427.82M | 14.18% | 47,156 | 1.24M |
| 234 | ALLO | Allogene Therapeutics, Inc. | 424.95M | 1.65% | 16,104,119 | 4.64M |
| 235 | AGMB | AgomAb Therapeutics NV | 413.68M | -1.98% | 89,798 | - |
| 236 | ASMB | Assembly Biosciences, Inc. | 413.32M | 3.20% | 185,733 | 74.85M |
| 237 | AUTL | Autolus Therapeutics plc | 412.55M | 1.31% | 1,785,030 | 117.39M |
| 238 | ZURA | Zura Bio Limited | 409.19M | 19.94% | 5,089,326 | - |
| 239 | PRLD | Prelude Therapeutics Incorporated | 399.62M | 4.86% | 277,485 | 22.42M |
| 240 | EDIT | Editas Medicine, Inc. | 399.31M | 8.33% | 3,079,367 | 47.01M |
| 241 | TECX | Tectonic Therapeutic, Inc. | 397.63M | 1.95% | 226,973 | - |
| 242 | ALT | Altimmune, Inc. | 396.82M | -0.49% | 4,967,610 | 31.00K |
| 243 | CCCC | C4 Therapeutics, Inc. | 394.91M | 7.72% | 4,119,735 | 35.04M |
| 244 | FENC | Fennec Pharmaceuticals Inc. | 372.41M | 4.63% | 93,186 | 59.22M |
| 245 | TRXB | TRex Bio, Inc. | 371.25M | -0.58% | 42,893 | - |
| 246 | SPRY | ARS Pharmaceuticals, Inc. | 370.94M | -4.85% | 1,643,512 | 116.93M |
| 247 | NAUT | Nautilus Biotechnology, Inc. | 367.77M | 18.44% | 20,698,716 | 424.00K |
| 248 | AVTX | Avalo Therapeutics, Inc. | 362.00M | -0.30% | 2,643,478 | 59.00K |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 354.75M | 1.50% | 319,429 | 65.26M |
| 250 | CAPR | Capricor Therapeutics, Inc. | 354.65M | 6.27% | 3,475,565 | 11.13M |
| 251 | KYTX | Kyverna Therapeutics, Inc. | 348.18M | 6.83% | 916,659 | - |
| 252 | OBIO | Orchestra BioMed Holdings, Inc. | 347.41M | 4.14% | 376,780 | 31.98M |
| 253 | RLMD | Relmada Therapeutics, Inc. | 342.41M | -0.62% | 1,673,659 | - |
| 254 | GALT | Galectin Therapeutics Inc. | 340.87M | 5.96% | 204,735 | - |
| 255 | CTNM | Contineum Therapeutics, Inc. | 338.21M | 10.44% | 643,755 | - |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 334.45M | 0.24% | 245,240 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 322.23M | - | 1,607,236 | 15.85M |
| 258 | VTVT | vTv Therapeutics Inc. | 319.57M | -0.35% | 11,157 | 36.84M |
| 259 | ARCT | Arcturus Therapeutics Holdings Inc. | 319.19M | 13.32% | 928,515 | 29.37M |
| 260 | ALEC | Alector, Inc. | 311.34M | 14.75% | 4,569,827 | 13.86M |
| 261 | TTRX | Turn Therapeutics Inc. | 310.39M | -1.79% | 98,415 | - |
| 262 | BNTC | Benitec Biopharma Inc. | 302.78M | 1.05% | 156,893 | - |
| 263 | SCTX | Scribe Therapeutics Inc. | 302.15M | 2.31% | 578,652 | 33.30M |
| 264 | EIKN | Eikon Therapeutics, Inc. | 300.35M | 0.09% | 697,272 | - |
| 265 | AGEN | Agenus Inc. | 299.39M | 7.95% | 839,018 | 132.69M |
| 266 | IRD | Opus Genetics, Inc. | 287.86M | 4.22% | 1,304,158 | 9.86M |
| 267 | IKT | Inhibikase Therapeutics, Inc. | 285.86M | 3.29% | 1,186,221 | 1.00 |
| 268 | VOGX | Vogenx, Inc. | 284.62M | 10.50% | 75,130 | - |
| 269 | FULC | Fulcrum Therapeutics, Inc. | 282.30M | 1.65% | 1,903,729 | 80.00M |
| 270 | SABS | SAB Biotherapeutics, Inc. | 279.33M | 10.04% | 646,573 | 114.70K |
| 271 | VCRE | Vicore Pharma Holding AB (publ) | 269.46M | -0.53% | 24,172 | 412.09K |
| 272 | RCKT | Rocket Pharmaceuticals, Inc. | 268.95M | 7.46% | 2,054,808 | - |
| 273 | BCYC | Bicycle Therapeutics plc | 264.57M | 3.56% | 486,231 | 61.21M |
| 274 | IPSC | Century Therapeutics, Inc. | 262.56M | 2.11% | 771,263 | 109.16M |
| 275 | LCTX | Lineage Cell Therapeutics, Inc. | 260.49M | 3.32% | 1,196,393 | 13.08M |
| 276 | QTTB | Q32 Bio Inc. | 259.29M | 3.08% | 692,683 | 53.74M |
| 277 | OCGN | Ocugen, Inc. | 256.84M | 6.92% | 8,687,433 | 4.58M |
| 278 | GLSI | Greenwich LifeSciences, Inc. | 255.69M | 1.69% | 224,304 | - |
| 279 | CUVL | Clinuvel Pharmaceuticals Limited | 254.66M | 1.21% | 3,225 | 65.05M |
| 280 | ABEO | Abeona Therapeutics Inc. | 254.47M | 3.25% | 663,678 | 25.52M |
| 281 | LRMR | Larimar Therapeutics, Inc. | 249.48M | 6.70% | 1,205,044 | - |
| 282 | FATE | Fate Therapeutics, Inc. | 248.03M | 0.73% | 923,557 | 6.49M |
| 283 | LYEL | Lyell Immunopharma, Inc. | 247.99M | 8.70% | 127,907 | 27.00K |
| 284 | IMRX | Immuneering Corporation | 247.79M | 3.23% | 700,080 | - |
| 285 | CABA | Cabaletta Bio, Inc. | 246.69M | 7.78% | 6,640,683 | - |
| 286 | IFRX | InflaRx N.V. | 244.63M | 5.40% | 513,064 | -11.54K |
| 287 | VNDA | Vanda Pharmaceuticals Inc. | 241.25M | 1.27% | 1,857,169 | 215.72M |
| 288 | LXEO | Lexeo Therapeutics, Inc. | 235.46M | 6.30% | 2,684,077 | - |
| 289 | CAMP | Camp4 Therapeutics Corporation | 229.05M | 13.71% | 260,819 | 4.22M |
| 290 | KROS | Keros Therapeutics, Inc. | 226.53M | 0.84% | 148,511 | 15.01M |
| 291 | ACIU | AC Immune SA | 223.71M | -2.60% | 469,026 | 21.67M |
| 292 | SLGL | Sol-Gel Technologies Ltd. | 223.25M | -2.07% | 38,787 | 1.80M |
| 293 | PYXS | Pyxis Oncology, Inc. | 219.80M | 8.88% | 1,183,688 | 11.04M |
| 294 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 215.67M | 1.89% | 1,755,926 | - |
| 295 | PALI | Palisade Bio, Inc. | 209.12M | -2.44% | 6,013,178 | 500.00K |
| 296 | ARTV | Artiva Biotherapeutics, Inc. | 208.76M | -30.68% | 8,673,747 | 251.00K |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 203.85M | 2.02% | 448,304 | 80.62M |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 196.03M | 9.05% | 935,285 | - |
| 299 | KRRO | Korro Bio, Inc. | 195.85M | 10.65% | 322,655 | 2.38M |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 195.45M | 2.87% | 118,819 | 1.48M |
| 301 | ACOG | Alpha Cognition Inc. | 194.04M | 7.35% | 152,590 | 15.26M |
| 302 | WHWK | Whitehawk Therapeutics, Inc. | 189.84M | 6.05% | 290,060 | 7.15M |
| 303 | PRQR | ProQR Therapeutics N.V. | 189.10M | 8.06% | 1,457,328 | 21.05M |
| 304 | ZNTL | Zentalis Pharmaceuticals, Inc. | 187.45M | -4.35% | 1,723,633 | 26.87M |
| 305 | DTIL | Precision BioSciences, Inc. | 187.41M | 5.93% | 164,248 | 45.06M |
| 306 | EVMN | Evommune, Inc. | 187.27M | 0.58% | 1,301,851 | 10.00M |
| 307 | YARW | Yarrow Bioscience, Inc. | 187.20M | 0.60% | 231,114 | - |
| 308 | CGEN | Compugen Ltd. | 186.61M | 5.07% | 131,409 | 74.00M |
| 309 | PEPG | PepGen Inc. | 180.07M | 4.42% | 1,332,000 | - |
| 310 | SION | Sionna Therapeutics, Inc. | 174.97M | 4.88% | 1,000,698 | - |
| 311 | IVVD | Invivyd, Inc. | 173.52M | -0.08% | 4,276,125 | 58.37M |
| 312 | ADAG | Adagene Inc. | 173.23M | 3.61% | 189,231 | 9.29M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 173.04M | 1.96% | 97,229 | 2.00M |
| 314 | CHRS | Coherus Oncology, Inc. | 165.32M | 5.94% | 605,840 | 50.94M |
| 315 | ABOS | Acumen Pharmaceuticals, Inc. | 163.46M | -0.44% | 1,797,778 | - |
| 316 | MDWD | MediWound Ltd. | 162.02M | 3.98% | 117,414 | 11.86M |
| 317 | NGEN | NervGen Pharma Corp. | 159.13M | 4.23% | 539,411 | - |
| 318 | TRDA | Entrada Therapeutics, Inc. | 159.01M | -7.16% | 413,454 | 4.69M |
| 319 | MGNX | MacroGenics, Inc. | 155.43M | 11.42% | 2,120,070 | 175.14M |
| 320 | UPB | Upstream Bio, Inc. | 152.81M | 1.45% | 1,179,622 | 3.16M |
| 321 | CNTN | Canton Strategic Holdings, Inc. | 152.19M | 4.95% | 733,806 | 1.50M |
| 322 | ALXO | ALX Oncology Holdings Inc. | 152.10M | -2.65% | 3,215,734 | - |
| 323 | STRO | Sutro Biopharma, Inc. | 147.07M | -0.22% | 453,236 | 45.70M |
| 324 | MSLE | Satellos Bioscience Inc. | 146.07M | 5.20% | 22,180 | - |
| 325 | TARA | Protara Therapeutics, Inc. | 145.97M | 5.11% | 1,842,966 | - |
| 326 | ANTX | AN2 Therapeutics, Inc. | 145.66M | 6.34% | 239,626 | - |
| 327 | MOLN | Molecular Partners AG | 145.60M | 6.13% | 1,896 | 856.30K |
| 328 | NBP | NovaBridge Biosciences | 145.58M | 3.29% | 437,986 | - |
| 329 | RNA | Atrium Therapeutics, Inc. | 142.32M | 3.35% | 198,573 | 35.84M |
| 330 | MENS | Jyong Biotech Ltd. | 141.79M | 7.91% | 19,856 | - |
| 331 | VRXA | Veraxa Biotech AG | 141.37M | 2.01% | 95,382 | 29.54K |
| 332 | CDXS | Codexis, Inc. | 140.17M | -1.54% | 691,461 | 77.68M |
| 333 | CMPX | Compass Therapeutics, Inc. | 134.60M | 0.03% | 2,210,325 | 850.00K |
| 334 | HURA | TuHURA Biosciences, Inc. | 134.46M | 3.43% | 401,221 | - |
| 335 | CUE | Cue Biopharma, Inc. | 133.08M | -0.70% | 115,062 | 37.66M |
| 336 | IPHA | Innate Pharma S.A. | 132.80M | 1.37% | 16,826 | 11.21M |
| 337 | SPRB | Spruce Biosciences, Inc. | 131.20M | 3.77% | 91,555 | 697.00K |
| 338 | ARMP | Armata Pharmaceuticals, Inc. | 129.77M | 1.16% | 104,310 | 5.54M |
| 339 | OTLK | Outlook Therapeutics, Inc. | 128.98M | 3.21% | 3,262,604 | -1.16M |
| 340 | HUMA | Humacyte, Inc. | 123.98M | 11.41% | 3,720,310 | 2.12M |
| 341 | NKTX | Nkarta, Inc. | 121.76M | -7.10% | 2,550,743 | - |
| 342 | FHTX | Foghorn Therapeutics Inc. | 121.74M | - | 874,691 | 36.74M |
| 343 | AVXL | Anavex Life Sciences Corp. | 121.43M | 2.34% | 1,351,156 | - |
| 344 | PYPD | PolyPid Ltd. | 117.20M | 9.07% | 229,103 | - |
| 345 | NRXP | NRx Pharmaceuticals, Inc. | 116.38M | 5.49% | 749,685 | 3.39M |
| 346 | ANIX | Anixa Biosciences, Inc. | 114.03M | 11.95% | 497,903 | - |
| 347 | RTSN | Retension Pharmaceuticals, Inc. | 112.64M | -5.06% | 75,341 | - |
| 348 | KZIA | Kazia Therapeutics Limited | 111.96M | 3.81% | 231,926 | 1.27M |
| 349 | TLSA | Tiziana Life Sciences Ltd | 111.64M | -1.17% | 190,528 | - |
| 350 | SEER | Seer, Inc. | 108.53M | 1.55% | 122,284 | 14.22M |
| 351 | VYGR | Voyager Therapeutics, Inc. | 106.60M | -1.14% | 1,269,755 | 34.46M |
| 352 | NERV | Minerva Neurosciences, Inc. | 106.48M | 1.36% | 239,278 | - |
| 353 | CBUS | Cibus, Inc. | 105.47M | -1.08% | 56,015 | 4.35M |
| 354 | OKUR | OnKure Therapeutics, Inc. | 105.09M | 4.85% | 320,237 | - |
| 355 | ENGN | enGene Therapeutics Inc. | 103.88M | -1.90% | 365,262 | - |
| 356 | IMUX | Immunic, Inc. | 103.83M | 4.53% | 356,208 | - |
| 357 | VANI | Vivani Medical, Inc. | 102.83M | 0.88% | 197,563 | - |
| 358 | UNCY | Unicycive Therapeutics, Inc. | 100.56M | 0.84% | 1,342,589 | - |
| 359 | BDTX | Black Diamond Therapeutics, Inc. | 100.54M | 3.55% | 1,099,330 | 70.00M |
| 360 | LENZ | LENZ Therapeutics, Inc. | 98.97M | 0.16% | 377,751 | 21.48M |
| 361 | TVGN | Tevogen Inc. | 98.83M | 0.48% | 5,139 | - |
| 362 | TENX | Tenax Therapeutics, Inc. | 98.52M | 4.88% | 1,672,167 | - |
| 363 | MIST | Milestone Pharmaceuticals Inc. | 97.40M | 7.26% | 754,472 | 2.34M |
| 364 | COYA | Coya Therapeutics, Inc. | 96.65M | 4.30% | 55,828 | 8.02M |
| 365 | PMVP | PMV Pharmaceuticals, Inc. | 94.39M | 10.62% | 375,170 | - |
| 366 | PDSB | PDS Biotechnology Corporation | 94.22M | 22.07% | 10,671,167 | - |
| 367 | PLYX | Polaryx Therapeutics, Inc. | 93.71M | 3.30% | 14,872 | - |
| 368 | ICCC | ImmuCell Corporation | 93.18M | 0.20% | 4,167 | 30.68M |
| 369 | TNXP | Tonix Pharmaceuticals Holding Corp. | 92.44M | 1.70% | 955,245 | 29.10M |
| 370 | NRXS | NeurAxis, Inc. | 92.43M | 1.52% | 38,920 | 5.32M |
| 371 | INO | Inovio Pharmaceuticals, Inc. | 92.02M | 2.32% | 3,798,877 | 65.34K |
| 372 | GNLX | Genelux Corporation | 91.86M | 7.33% | 1,452,185 | 8.00K |
| 373 | CNXU | Conexeu Sciences Inc. | 90.95M | 0.34% | 224,061 | - |
| 374 | TNYA | Tenaya Therapeutics, Inc. | 90.01M | -1.76% | 2,140,841 | 1.34M |
| 375 | PMN | ProMIS Neurosciences, Inc. | 86.81M | 20.10% | 53,060 | - |
| 376 | EQ | Equillium, Inc. | 86.23M | 8.80% | 345,667 | 4.39M |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 84.93M | -1.28% | 329,612 | 4.88M |
| 378 | RLYB | Rallybio Corporation | 84.60M | -4.32% | 52,620 | 434.00K |
| 379 | ATRA | Atara Biotherapeutics, Inc. | 83.31M | -0.60% | 21,699 | 6.19M |
| 380 | CING | Cingulate Inc. | 80.42M | 6.76% | 294,880 | - |
| 381 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 80.27M | 4.01% | 716,710 | - |
| 382 | CLLS | Cellectis S.A. | 78.94M | 8.64% | 78,301 | 63.82M |
| 383 | OKYO | OKYO Pharma Limited | 78.19M | 3.47% | 11,312 | - |
| 384 | TELO | Telomir Pharmaceuticals, Inc. | 75.09M | 2.15% | 55,550 | - |
| 385 | NTHI | NeOnc Technologies Holdings, Inc. | 74.57M | 6.38% | 69,923 | 39.99K |
| 386 | ACRV | Acrivon Therapeutics, Inc. | 74.56M | 1.16% | 168,540 | - |
| 387 | NTRB | Nutriband Inc. | 72.33M | -0.34% | 11,708 | 1.62M |
| 388 | CGTX | Cognition Therapeutics, Inc. | 72.19M | 9.24% | 324,289 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 71.17M | 5.41% | 301,109 | - |
| 390 | MNOV | MediciNova, Inc. | 69.40M | 0.71% | 37,751 | 920.48K |
| 391 | NMRA | Neumora Therapeutics, Inc. | 69.16M | -6.31% | 1,744,660 | - |
| 392 | CRDF | Cardiff Oncology, Inc. | 68.08M | 8.80% | 647,550 | 508.00K |
| 393 | CSBR | Champions Oncology, Inc. | 67.23M | -0.62% | 3,402 | 60.66M |
| 394 | SPRO | Spero Therapeutics, Inc. | 66.39M | 6.54% | 507,846 | 47.00M |
| 395 | FBIO | Fortress Biotech, Inc. | 64.37M | 3.21% | 157,135 | 68.47M |
| 396 | RNXT | RenovoRx, Inc. | 62.73M | 6.11% | 289,416 | 1.98M |
| 397 | RNTX | Rein Therapeutics Inc. | 60.75M | 20.75% | 622,144 | - |
| 398 | GOSS | Gossamer Bio, Inc. | 59.76M | 6.78% | 138,044 | 53.29M |
| 399 | VRCA | Verrica Pharmaceuticals Inc. | 59.61M | 1.46% | 27,987 | 30.32M |
| 400 | ONCY | Oncolytics Biotech Inc. | 58.95M | -2.30% | 859,328 | - |
| 401 | HRTX | Heron Therapeutics, Inc. | 57.24M | 0.27% | 1,140,081 | 151.18M |
| 402 | OSTX | OS Therapies Incorporated | 56.83M | 1.65% | 318,150 | - |
| 403 | CLNN | Clene Inc. | 56.43M | 3.39% | 31,305 | 197.00K |
| 404 | XBIT | XBiotech Inc. | 56.40M | - | 69,107 | - |
| 405 | PTHS | Pelthos Therapeutics Inc. | 55.51M | -4.61% | 73,232 | 43.30M |
| 406 | BOLD | Boundless Bio, Inc. | 54.82M | - | 91,087 | - |
| 407 | HYFT | MindWalk Holdings Corp. | 54.65M | 0.87% | 78,645 | 11.57M |
| 408 | INKT | MiNK Therapeutics, Inc. | 54.24M | 1.92% | 10,146 | - |
| 409 | ALPS | Alps Group Inc | 54.05M | -0.85% | 35,443 | 3.74M |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 53.85M | 1.29% | 10,469 | - |
| 411 | PLRX | Pliant Therapeutics, Inc. | 53.07M | 0.86% | 346,676 | - |
| 412 | CNTB | Connect Biopharma Holdings Limited | 53.06M | -0.75% | 570,807 | 2.95M |
| 413 | XLO | Xilio Therapeutics, Inc. | 52.71M | 9.58% | 27,934 | 64.09M |
| 414 | GANX | Gain Therapeutics, Inc. | 51.06M | 1.74% | 508,340 | - |
| 415 | HOWL | Werewolf Therapeutics, Inc. | 50.54M | 6.06% | 308,103 | 21.00M |
| 416 | CRBU | Caribou Biosciences, Inc. | 49.39M | -6.40% | 2,368,163 | 10.04M |
| 417 | IBIO | iBio, Inc. | 49.32M | 8.47% | 478,170 | 100.00K |
| 418 | ELTX | Elicio Therapeutics, Inc. | 48.10M | 7.65% | 342,385 | - |
| 419 | MREO | Mereo BioPharma Group plc | 46.58M | 6.07% | 291,326 | 500.00K |
| 420 | BMEA | Biomea Fusion, Inc. | 46.56M | 1.07% | 1,312,033 | - |
| 421 | HYPD | Hyperion DeFi, Inc. | 46.46M | 4.91% | 104,127 | 1.40M |
| 422 | LONA | LeonaBio, Inc. | 46.07M | 2.73% | 118,702 | - |
| 423 | IMA | ImageneBio, Inc. | 45.63M | -0.74% | 4,138 | 800.00K |
| 424 | ATNM | Actinium Pharmaceuticals, Inc. | 44.65M | 1.43% | 106,954 | 35.09M |
| 425 | KLRS | Kalaris Therapeutics, Inc. | 44.28M | 3.33% | 51,128 | - |
| 426 | APLM | Apollomics, Inc. | 42.95M | -1.71% | - | 8.84M |
| 427 | ANVS | Annovis Bio, Inc. | 42.61M | 4.49% | 913,324 | - |
| 428 | SER | Serina Therapeutics, Inc. | 42.42M | -2.34% | 172,034 | 130.00K |
| 429 | INMB | INmune Bio Inc. | 42.19M | 6.29% | 274,778 | 50.00K |
| 430 | GRDX | GridAI Technologies Corp. | 41.32M | 5.14% | 94,569 | - |
| 431 | ACET | Adicet Bio, Inc. | 41.01M | -3.30% | 178,167 | - |
| 432 | ESLA | Estrella Immunopharma, Inc. | 40.55M | 1.47% | 614,632 | - |
| 433 | TIL | Instil Bio, Inc. | 39.61M | 4.85% | 102,053 | - |
| 434 | DWTX | Dogwood Therapeutics, Inc. | 39.43M | 4.50% | 28,555 | - |
| 435 | GRCE | Grace Therapeutics, Inc. | 39.34M | 3.31% | 110,536 | - |
| 436 | VERU | Veru Inc. | 38.87M | 3.17% | 157,713 | 16.89M |
| 437 | ALDX | Aldeyra Therapeutics, Inc. | 38.68M | -0.08% | 991,812 | - |
| 438 | ATHE | Alterity Therapeutics Limited | 38.67M | 2.88% | 3,527 | 2.50M |
| 439 | NNVC | NanoViricides, Inc. | 37.27M | 7.35% | 237,386 | - |
| 440 | EDSA | Edesa Biotech, Inc. | 35.54M | 1.54% | 25,869 | - |
| 441 | EXOZ | eXoZymes, Inc. | 35.27M | 1.33% | 16,652 | -700.00 |
| 442 | LITS | Lite Strategy, Inc. | 35.12M | 3.12% | 105,226 | - |
| 443 | CRVO | CervoMed Inc. | 33.56M | -0.89% | 150,558 | 331.30K |
| 444 | IRLA | IRulya Therapeutics Inc. | 33.03M | 3.49% | 127,518 | - |
| 445 | FLNA | Filana Therapeutics, Inc. | 31.32M | 5.97% | 295,676 | - |
| 446 | EYPT | EyePoint, Inc. | 31.31M | -0.68% | 9,675,330 | 2.79M |
| 447 | BCTX | BriaCell Therapeutics Corp. | 31.03M | 1.71% | 49,881 | - |
| 448 | IBO | Impact BioMedical Inc. | 30.33M | -4.83% | 12,270 | 35.00K |
| 449 | MGX | Metagenomi Therapeutics, Inc. | 30.22M | 4.25% | 204,703 | 13.56M |
| 450 | ALGS | Aligos Therapeutics, Inc. | 29.60M | 1.94% | 9,528 | 31.52M |
| 451 | AARD | Aardvark Therapeutics, Inc. | 28.45M | 20.37% | 4,282,839 | - |
| 452 | RNAZ | TransCode Therapeutics, Inc. | 28.27M | -2.11% | 7,503 | - |
| 453 | CVM | CEL-SCI Corporation | 27.61M | -1.26% | 117,639 | - |
| 454 | BSEM | BioStem Technologies, Inc. | 27.51M | -3.90% | 185,898 | 34.59M |
| 455 | ABVC | ABVC BioPharma, Inc. | 27.26M | - | 24,225 | 797.92K |
| 456 | NXTC | NextCure, Inc. | 26.16M | 9.27% | 142,088 | - |
| 457 | CELU | Celularity Inc. | 25.64M | 5.36% | 219,290 | 18.67M |
| 458 | IGC | IGC Pharma, Inc. | 25.63M | -0.80% | 142,296 | 1.11M |
| 459 | EVAX | Evaxion A/S | 25.35M | -1.30% | 75,745 | 7.49M |
| 460 | IMMP | Immutep Limited | 24.88M | 1.61% | 13,558 | 13.79M |
| 461 | ATOS | Atossa Therapeutics, Inc. | 23.75M | -2.86% | 24,835 | - |
| 462 | CNTX | Context Therapeutics Inc. | 21.56M | -2.17% | 1,811,485 | - |
| 463 | PLRZ | Polyrizon Ltd. | 20.84M | -4.24% | 5,287 | - |
| 464 | QNTM | Quantum BioPharma Ltd. | 19.65M | 4.98% | 86,828 | - |
| 465 | AKTX | Akari Therapeutics, Plc | 19.61M | 12.45% | 38,456 | - |
| 466 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.46M | 1.00% | 1,522 | - |
| 467 | BYSI | BeyondSpring Inc. | 19.00M | 0.46% | 41,165 | 1.88M |
| 468 | COCP | Cocrystal Pharma, Inc. | 18.90M | 0.93% | 17,481 | 330.00K |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 18.34M | 0.30% | 3,639 | 1.17M |
| 470 | KYNB | Kyntra Bio, Inc. | 18.22M | - | 6,452 | 4.62M |
| 471 | MCRB | Seres Therapeutics, Inc. | 18.08M | -9.09% | 165,351 | 1.88M |
| 472 | JSPR | Jasper Therapeutics, Inc. | 17.27M | 2.67% | 1,324,168 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 15.86M | 4.95% | 103,959 | 3.55M |
| 474 | NCEL | NewcelX Ltd. | 15.83M | 7.45% | 12,391 | - |
| 475 | PLUR | Pluri Inc. | 14.69M | 6.25% | 132,783 | 1.02M |
| 476 | ALLR | Allarity Therapeutics, Inc. | 14.64M | 0.54% | 136,056 | 345.00K |
| 477 | KPRX | Kiora Pharmaceuticals, Inc. | 14.64M | 4.07% | 16,522 | 20.00K |
| 478 | DYAI | Dyadic International, Inc. | 14.32M | -5.55% | 159,935 | 3.80M |
| 479 | BCDA | BioCardia, Inc. | 13.95M | 2.22% | 37,114 | 3.00K |
| 480 | CTXR | Citius Pharmaceuticals, Inc. | 13.77M | 11.62% | 525,538 | 7.11M |
| 481 | KTTA | Pasithea Therapeutics Corp. | 13.28M | -0.65% | 649,428 | - |
| 482 | ICU | SeaStar Medical Holding Corporation | 13.26M | 2.02% | 76,748 | 1.71M |
| 483 | DARE | Daré Bioscience, Inc. | 13.04M | 2.98% | 52,089 | 1.37M |
| 484 | TCRX | TScan Therapeutics, Inc. | 13.01M | 1.21% | 541,034 | 7.11M |
| 485 | CNSY | Cerenome, Inc. | 12.60M | 5.73% | 51,152 | 4.20M |
| 486 | AEON | AEON Biopharma, Inc. | 12.39M | 3.46% | 140,150 | - |
| 487 | BOLT | Bolt Biotherapeutics, Inc. | 12.27M | -3.34% | 177,798 | 4.70M |
| 488 | RADX | Radiopharm Theranostics Limited | 12.20M | -9.64% | 25,072 | 8.90M |
| 489 | ATYR | aTyr Pharma, Inc. | 12.16M | -19.17% | 8,556,442 | 190.00K |
| 490 | LPCN | Lipocine Inc. | 12.04M | 0.69% | 129,470 | 1.57M |
| 491 | HIND | Vyome Holdings, Inc. | 11.93M | -0.58% | 5,030 | 129.73K |
| 492 | GUTS | Fractyl Health, Inc. | 11.67M | -17.76% | 1,219,276 | 3.00K |
| 493 | TVRD | Tvardi Therapeutics, Inc. | 11.54M | 2.76% | 72,750 | - |
| 494 | PBM | Psyence Biomedical Ltd. | 11.48M | -17.76% | 244,845 | - |
| 495 | CLRB | Cellectar Biosciences, Inc. | 11.44M | - | 161,585 | - |
| 496 | KPTI | Karyopharm Therapeutics Inc. | 10.89M | -0.44% | 996,614 | 146.62M |
| 497 | BIVI | BioVie Inc. | 10.86M | 8.27% | 196,227 | - |
| 498 | PASG | Passage Bio, Inc. | 10.78M | -0.27% | 3,993 | - |
| 499 | GDTC | CytoMed Therapeutics Limited | 10.62M | -3.91% | 16,967 | 609.73K |
| 500 | PPBT | Purple Biotech Ltd | 10.49M | -8.51% | 21,654 | - |